Pramodini Medicare IPO
Pramodini Medicare Limited, founded in 2000, is one of the leading diagnostic services providers in India across radiology, clinical laboratory, and nuclear medicine segments. Its service portfolio includes radiology services such as MRI, CT scans, X-ray, ultrasound with colour Doppler, mammography, DEXA scan, and interventional radiology; clinical laboratory services including haematology, microbiology, immunology, pathology, and biochemistry; and nuclear medicine services such as PET-CT, SPECT, and nuclear therapy.
IPO GMP
₹0
+0% expected gain
Price Band
₹118
Lot Size
2400 shares
Min Investment
₹2,83,200
Listing Date
August 19, 2026
About Pramodini Medicare
Company overview, business, and key facts.
Pramodini Medicare Limited, founded in 2000, is one of the leading diagnostic services providers in India across radiology, clinical laboratory, and nuclear medicine segments. Its service portfolio includes radiology services such as MRI, CT scans, X-ray, ultrasound with colour Doppler, mammography, DEXA scan, and interventional radiology; clinical laboratory services including haematology, microbiology, immunology, pathology, and biochemistry; and nuclear medicine services such as PET-CT, SPECT, and nuclear therapy.
Pramodini Medicare operates diagnostic centres through Public-Private Partnerships (PPP), Private-Private Partnerships (Pvt-Pvt), Strategic Partnerships with PSUs, Standalone Diagnostic Centres, and Location-Specific Agreements. The firm has its presence across Vijayawada, Hyderabad, Kurnool, Kapada, Tirupati, Varanasi, Prayagraj, and many others.
Founded
2000
Headquarters
Vijayawada, Andhra Pradesh
Website
https://www.pramodinidiagnostics.com/
IPO Details
Subscription Status
How many times each investor category has bid for the issue.
Strengths & Risks
Strengths
- Review: Neutral
Risks
Financials
Restated summary financials for the most recent periods.
Figures are indicative and restated for presentation.
Pramodini Medicare IPO Key Numbers
Calculated by IPOLyst from the published offer-document data. These are figures, not buy or sell calls.
Market cap at upper band
₹260.1 Cr
Post-IPO shares × upper price band
P/E on 2026 profit
15x
Peer median 13.6x (premium of 10.3%)
Price to sales
4.1x
Revenue growth, 2026
+64.4%
33.1% a year over the period
Profit growth, 2026
+56%
56% a year over the period
Profit margin (PAT)
27.4%
EBITDA margin 49.61%
ROE / ROCE
39.08% / 34.66%
As published in the offer document
Debt to equity
0.34
Promoter holding
85.71% → 62.64%
Before → after the IPO
Issue mix
91.5% fresh / 8.5% sale
Fresh issue goes to the company, offer for sale to selling shareholders
GMP-implied gain per lot
₹0
2400 shares on ₹2,83,200. GMP is unofficial.
What stands out
- Healthy profit margin: PAT margin was 27.4% in 2026.
- Profit grew 56% in 2026.
Watch-outs
- 1 use-of-proceeds item(s) have no disclosed amount.
Scenarios apply today's grey market premium figures to the upper price band. They are illustrations, not predictions. GMP is unofficial and can be wrong.
Not yet available for this IPO: published risk factors.
IPO Analysis SummaryAI-generated
A plain-language review of Pramodini Medicare's financials, valuation and demand, based only on the verified figures above. For information only. It does not recommend whether to apply.
Pramodini Medicare IPO Review
Analysis based on live GMP, subscription, and issue details.
Pramodini Medicare IPO is currently showing a neutral GMP of ₹0, suggesting the market is cautious about listing gains.
The IPO has been subscribed 3.63x overall — QIB: 3.66x, NII: 3.93x, Retail: 3.42x.
Pramodini Medicare IPO subscription has closed. The shares are expected to list on August 19, 2026.
The minimum investment required is ₹2,83,200 for 2400 shares (1 lot). Retail investors can apply at cut-off price for the best chance of allotment.
Key strengths include: Review: Neutral.
Disclaimer: IPO GMP is indicative and sourced from the grey market. This is not investment advice. Please consult a SEBI-registered advisor before investing.
Pramodini Medicare IPO — Frequently Asked Questions
What is Pramodini Medicare IPO GMP today?
Pramodini Medicare IPO GMP (grey market premium) today is ₹0, suggesting an estimated listing gain of +0%. GMP is indicative and subject to change.
What is the price band of Pramodini Medicare IPO?
The price band for Pramodini Medicare IPO is ₹118 with a lot size of 2400 shares. The minimum investment required is ₹2,83,200.
When is Pramodini Medicare IPO allotment date?
Pramodini Medicare IPO allotment is expected to be finalised on August 17, 2026. You can check your allotment status on the registrar's website (Purva Sharegistry (India) Pvt. Ltd.) using your PAN number.
When will Pramodini Medicare IPO list on NSE/BSE?
Pramodini Medicare IPO is expected to list on NSE SME on August 19, 2026.
How to check Pramodini Medicare IPO allotment status?
To check Pramodini Medicare IPO allotment status, visit the registrar's website (Purva Sharegistry (India) Pvt. Ltd.) and enter your PAN number, application number, or DP/Client ID. You can also check on the BSE IPO allotment page at https://www.bseindia.com/investors/appli_check.aspx.
Should I apply for Pramodini Medicare IPO?
Pramodini Medicare IPO has a GMP of ₹0. Before applying, review the company's financials, business model, issue structure (OFS vs fresh issue), and sector outlook. IPOLyst is not a SEBI-registered investment advisor — please consult a qualified financial advisor before investing.
What is the lot size of Pramodini Medicare IPO?
The lot size for Pramodini Medicare IPO is 2400 shares per lot. The minimum investment for retail investors is ₹2,83,200. Retail investors can apply for a maximum of 13 lots or up to ₹2 lakh, whichever is lower.